Levocetirizine + Montelukast + Ambroxol Tablets
Each film-coated sustained-release tablet contains:
Levocetirizine Dihydrochloride IP – 5 mg
Montelukast Sodium IP (as Montelukast) – 10 mg
Ambroxol Hydrochloride IP – 75 mg (in sustained-release form)
Dosage Form: Sustained Release Tablet
Pharmacological Classification:
Antihistamine
Leukotriene Receptor Antagonist
Mucolytic & Expectorant
Pack | 10 x 10 (Alu Alu) |
---|---|
Composition | Levocetirizine 5 mg + Montelukast 10 + Ambroxol 75 mg (SR) Tablets |